AVEO PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Aveo Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2022.
  • Aveo Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2022 was 34.6M shares, a 0.72% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 34.6M +247K +0.72% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 34.6M +240K +0.7% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 34.5M +114K +0.33% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 34.5M +7.59M +28.2% Dec 31, 2021 10-Q 2022-11-07
Q3 2021 34.4M +8.57M +33.2% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 34.4M +8.57M +33.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 34.4M +7.48M +27.8% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 26.9M +10.8M +67.2% Dec 31, 2020 10-K 2022-03-14
Q3 2020 25.8M -135M -83.9% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 25.8M -135M -83.9% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 26.9M -112M -80.7% Mar 31, 2020 10-K 2021-03-16
Q4 2019 16.1M +3.43M +27.1% Dec 31, 2019 10-K 2021-03-16
Q3 2019 161M +39.2M +32.3% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 161M +41.7M +35.1% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 139M +20.1M +16.9% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 12.6M -106M -89.3% Dec 31, 2018 10-K 2020-03-16
Q3 2018 122M +3.22M +2.72% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 119M +2.16M +1.85% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 119M +8.5M +7.71% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 118M +42.5M +56% Dec 31, 2017 10-K 2019-03-14
Q3 2017 118M +42.5M +56% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 117M +41M +54% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 110M +52.2M +89.7% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 75.9M +17.7M +30.4% Dec 31, 2016 10-K 2018-03-13
Q3 2016 75.9M +17.7M +30.4% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 75.9M +23.6M +45.1% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 58.2M +3.17M +5.77% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 58.2M +5.89M +11.3% Dec 31, 2015 10-K 2017-03-22
Q3 2015 58.2M +5.93M +11.3% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 52.3M -14K -0.03% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 55M +2.75M +5.25% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 52.3M +480K +0.93% Dec 31, 2014 10-K 2016-03-15
Q3 2014 52.2M +30K +0.06% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 52.3M +85K +0.16% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 52.3M +414K +0.8% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 51.8M +8.03M +18.3% Dec 31, 2013 10-K 2015-03-06
Q3 2013 52.2M +8.48M +19.4% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 52.2M +8.58M +19.7% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 51.8M +8.29M +19% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 43.8M +526K +1.22% Dec 31, 2012 10-K 2014-03-13
Q3 2012 43.7M +550K +1.27% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 43.6M +741K +1.73% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 43.6M Mar 31, 2012 10-Q 2012-05-09
Q4 2011 43.3M +7.65M +21.5% Dec 31, 2011 10-K 2013-03-11
Q3 2011 43.2M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 42.9M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 35.6M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.